Earlier this year ProPublica published an article implying that Averhealth’s forensic drug testing cannot be trusted, a claim no court, regulator or plaintiff has ever substantiated. In an op-ed published October 27 by The Washington Times, Averhealth CEO Dominique Hummel explains what the article left out and why the company has taken ProPublica to court. […]
Read MoreFor the Record
ProPublica: Journalism in the Public Interest?
This article — under both its original headline and its later, retitled version (“A Drug Testing Company Favored Speed Over Reliability, Some Ex-Employees Say. The Firm Says Its Work Is ‘Accurate.’”) — is built passage by passage to leave readers with one implication: that Averhealth’s laboratory produces false positives at a rate that makes its […]
Read MoreAverhealth Files Defamation Suit Against ProPublica
In January 2026, ProPublica and reporter Alice Hines published a story about Averhealth that paints an inaccurate and distorted picture of our company, most egregiously by suggesting that our drug testing is materially inaccurate. That claim is false. ProPublica and Hines knew it was false and published it anyway. On August 26, 2026 we filed […]
Read More
